Negative Pressure Wound Therapy Market

Report Overview

The global negative pressure wound therapy market was pegged at US$ 2.5 billion in 2021 and is expected to witness a CAGR of 5.9% during the forecast period.

Market Fundamentals

Negative pressure wound therapy (NPWT), or vacuum-assisted wound closure is a wound care system that constantly or immediately applies vacuum pressure on the wound. This therapy has gained high popularity for treating acute or chronic open injuries. The usage of negative pressure wound therapy focuses on the withdrawal of fluids and infections which help in fast healing. This therapy reduces the risk of microbial infection, enhances tissue insertion by closing the wound, and increased blood circulation. A different bandage is used to cover the injury and a machine consisting of a gentle pump is attached to the wound which provides suction of about 50 to 125 mmHg this suction is known as negative pressure on the wound. 

[876534]

Market Dynamics

The growing demand for negative pressure wound therapy is owing to the increased expenditure on wound care, initiatives taken by healthcare facilities to prevent surgical site infections (SSIs), rising prevalence of diabetes, and a rise in the number of accidents. However, a lack of trained personnel and complications arising during the therapy can restrain the market growth, also, a lack of awareness & understanding, and the high cost of the therapy can be a challenge to this market. 

Market Ecosystem

The global negative pressure wound therapy market has been analyzed from four perspectives: product, wound type, end user, and region.

Negative Pressure Wound Therapy Market by Product      

[576343]                     

Negative pressure wound therapy is operated by a special device vacuum-assisted closure device. This device contains a drainage tube that pulls all the exudates out and collects it in a canister, a vacuum pump that produces pressure, dressing foam applied on the wound, and a film seal used for the closure of the wound. Based on the products, the negative pressure wound therapy market is classified into conventional products and disposable products among which conventional product has the highest stake in the market. Some of the factors which contribute to the growth of this type of product are better management of these devices in severe injuries makes them more valuable, these are cost-effective, also these are FDA class-II approved devices that instill trust in consumers, customer-friendly application, canister-free. Furthermore, the market for disposable devices is expected to grow dramatically in the coming years because using single-use devices reduces contamination and is also budget-friendly. 

Negative Pressure Wound Therapy Market by Wound Type

Based on wounds, the market has been segmented into chronic wounds and acute wounds. Between these, chronic wounds occupy larger revenue share. Such wounds are further classified into diabetic foot ulcers and pressure foot ulcers. As the number of diabetic cases leading to ulceration is increasing and casualties from accidents rise, the recommendation for negative pressure wound therapy will significantly rise. 

Negative Pressure Wound Therapy Market by Region

Regionally, the global negative pressure wound therapy market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America has occupied the highest share of this market followed by the Asia Pacific. The dominance of North America is owing to factors such as easy availability of NPWT systems, increasing awareness about the therapy, a high number of patients suffering from diabetes and some other chronic diseases, also the presence of several market players in this region. After North America, Asia pacific in the forecast period from 2022 to 2030, is expected to grow at the fastest rate owing to the factors such as the high population rate leading to many chronic diseases like diabetes which leads to many types of ulcers. An estimation from International Diabetes Federation (IDF), there will be over 400 million diabetics worldwide by 2025, with Asia, Africa, and Latin America having the greatest number of cases. Furthermore, approximately 25% of these patients are expected to develop foot ulcers over the course of their lives

Competitive Landscape

Some of the prominent players operating in the global Negative Pressure Wound Therapy market include 

• Smith & Nephew. plc
• Acetyl L.P. Inc
• Cardinal Health, Inc
• Alleva Medical Ltd
• Molnlycne Health care AB
• 4L Health co. Ltd
• DeRoyal Industries Inc
• Triage Meditech Pvt. Ltd
• Medela India Pvt. Ltd
• Convatec Group Plc
• Paul Hartman AG
• Among others

Strategic Developments

• Joerns Healthcare, a prominent wound care supplier, announced a nationwide partnership with the Medela line in April 2021 this will expand access to innovative negative pressure wound therapy. Joerns will develop its wound care portfolio which will include the Invia liberty and Invia Motion 60 NPWT Techniques, as part of its contract.
• Smith & Nephew has announced the construction of a new R&D and manufacturing facility for its Advanced Wound Management franchise on the outskirts of Hull, UK.

Frequently Asked Questions About This Report